TherapeuticsMD, Inc. (NYSE MKT:TXMD) announced today that the Company will present at the 9
Annual JMP Securities Healthcare Conference taking place at the Westin New York Grand Central on June 24-25, 2014.
Robert Finizio, Co-Founder and Chief Executive Officer of TherapeuticsMD, will present on Tuesday, June 24, 2014 at 1:30 p.m. EDT.
To listen to the live audio webcast of the presentation during the event, please visit the Company's website at
Events and Presentations
tab. A replay of this webcast will be available for 30 days after the initial presentation. The presentation may contain forward-looking statements.
About TherapeuticsMD, Inc.
TherapeuticsMD, Inc. is a women’s healthcare company focused on developing and commercializing products targeted exclusively for women. We are developing advanced hormone therapy pharmaceutical products based on novel technologies that enable delivery of bioidentical hormones through a variety of dosage forms and administration routes. We also manufacture and distribute branded and generic prescription prenatal vitamins, as well as over-the-counter vitamins and cosmetics, under our vitaMedMD
brands. More information is available at the following websites: